Panacea Life Sciences Holdings, Inc.
PLSH· OTC
PLSHPanacea Life Sciences Holdings, Inc.
Filed Apr 2, 2018 · 10-K · 92 days after period end · 0001654954-18-003508
derived · Computed from the longer spans the company filed.
| Metric | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $213.00 | — |
| Net Income | -$2.04M | -$747.43K | -$68.91K | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Panacea Life Sciences Holdings, Inc. · CIK 1552189 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Apr 2, 2018 · 92 d after period end
